Dennis J. Hartigan-O'Connor, Ph.D. - Publications

2003 University of Michigan, Ann Arbor, Ann Arbor, MI 
muscle gene therapy, DMD

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Santos Rocha C, Hirao LA, Weber MG, Méndez-Lagares G, Chang WLW, Jiang G, Deere JD, Sparger EE, Roberts J, Barry PA, Hartigan-O'Connor DJ, Dandekar S. Subclinical cytomegalovirus infection associates with altered host immunity, gut microbiota and vaccine responses. Journal of Virology. PMID 29669841 DOI: 10.1128/Jvi.00167-18  0.343
2017 Méndez-Lagares G, Lu D, Merriam D, Baker CA, Villinger F, Van Rompay KKA, McCune JM, Hartigan-O'Connor DJ. IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8(+) T Cell Responses in Acute Simian Immunodeficiency Virus Infection. Aids Research and Human Retroviruses. 33: S81-S92. PMID 29140110 DOI: 10.1089/Aid.2017.0160  0.337
2017 Merriam DP, Chen C, Mendez-Lagares G, Rogers K, Michaels A, Yan J, Casaz P, Reimann K, Villenger F, Hartigan-O'Connor DJ. Depletion of gut-resident CCR5+ cells for HIV cure strategies. Aids Research and Human Retroviruses. PMID 28918646 DOI: 10.1089/Aid.2017.0159  0.312
2011 Hartigan-O'Connor DJ, Jacobson MA, Tan QX, Sinclair E. Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 409-17. PMID 21189271 DOI: 10.1093/Cid/Ciq112  0.331
2004 Mi J, Barker S, Meuse L, Sawatzki S, Hartigan-O'Connor D, Chamberlain JS. 460. Immunogenicity of E2b-Deleted Adenoviral Vectors Compared with First Generation Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.426  0.46
2004 Mi J, Leuse L, Scott J, Barker S, Sawatzki S, Hartigan-O'Connor D, Chamberlain JS. 240. Immunogenicity of Dystrophins Delivered to Mice by Gutted Adenoviral Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.176  0.565
2002 DelloRusso C, Scott JM, Hartigan-O'Connor D, Salvatori G, Barjot C, Robinson AS, Crawford RW, Brooks SV, Chamberlain JS. Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proceedings of the National Academy of Sciences of the United States of America. 99: 12979-84. PMID 12271128 DOI: 10.1073/Pnas.202300099  0.612
2002 Barjot C, Hartigan-O'Connor D, Salvatori G, Scott JM, Chamberlain JS. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses. The Journal of Gene Medicine. 4: 480-9. PMID 12221641 DOI: 10.1002/Jgm.305  0.497
2002 Hartigan-O'Connor D, Chamberlain JS. Progress toward gene therapy of Duchenne muscular dystrophy. Seminars in Neurology. 19: 323-32. PMID 12194388 DOI: 10.1055/s-2008-1040848  0.481
2002 Hartigan-O'Connor D, Barjot C, Salvatori G, Chamberlain JS. Generation and growth of gutted adenoviral vectors. Methods in Enzymology. 346: 224-46. PMID 11883070 DOI: 10.1016/S0076-6879(02)46058-2  0.474
2002 Hartigan-O'Connor D, Barjot C, Crawford R, Chamberlain JS. Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection. Human Gene Therapy. 13: 519-31. PMID 11874630 DOI: 10.1089/10430340252809810  0.532
2001 Hartigan-O'Connor D, Kirk CJ, Crawford R, Mulé JJ, Chamberlain JS. Immune evasion by muscle-specific gene expression in dystrophic muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 525-33. PMID 11735336 DOI: 10.1006/Mthe.2001.0496  0.652
2000 Hauser MA, Robinson A, Hartigan-O'Connor D, Williams-Gregory DA, Buskin JN, Apone S, Kirk CJ, Hardy S, Hauschka SD, Chamberlain JS. Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 16-25. PMID 10899824 DOI: 10.1006/Mthe.2000.0089  0.677
2000 Hartigan-O'Connor D, Chamberlain JS. Developments in gene therapy for muscular dystrophy. Microscopy Research and Technique. 48: 223-38. PMID 10679969 DOI: 10.1002/(Sici)1097-0029(20000201/15)48:3/4<223::Aid-Jemt10>3.0.Co;2-L  0.639
1999 Hartigan-O'Connor D, Amalfitano A, Chamberlain JS. Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase Journal of Virology. 73: 7835-7841. PMID 10438876 DOI: 10.1128/Jvi.73.9.7835-7841.1999  0.464
Show low-probability matches.